PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation.
Murati
A
A
Gelsi-Boyer
V
V
Adélaïde
J
J
Perot
C
C
Talmant
P
P
Giraudier
S
S
Lodé
L
L
Letessier
A
A
Delaval
B
B
Brunel
V
V
Imbert
M
M
Garand
R
R
Xerri
L
L
Birnbaum
D
D
Mozziconacci
M J
MJ
Chaffanet
M
M
D000328:Adult; D001324:Autoantigens; D018797:Cell Cycle Proteins / Q000235:genetics*; D002648:Child; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D005260:Female; D006801:Humans; D053614:Janus Kinase 2; D004915:Leukemia, Erythroblastic, Acute / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D014178:Translocation, Genetic
D001324:Autoantigens; D018797:Cell Cycle Proteins; D015514:Oncogene Proteins, Fusion; C086074:PCM1 protein, human; D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2